Powered by Bioz
The Benefits of Glass BCTs
When developing critical assays, such as liquid biopsy-based cancer tests and pre-natal genetic screening kits, the composition of blood collection tu…
Read More 
The stopper color of Streck Cell-Free DNA BCT will change from mottled to tan starting with lot 3333. For additional information, refer to the resources section of this page.
Cell-Free DNA BCT®
For In Vitro Diagnostic Use
Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing assays that have been cleared or approved for use with samples collected into the Cell-Free DNA BCT device.
Performance characteristics of this device have only been established on the Guardant360® CDx assay and Guardant Shield™ assay.
Product Description
Cell-Free DNA BCT stabilizes cell-free DNA for up to 7 days. It contains a preservative reagent that reduces the release of contaminating cellular genomic DNA that can occur during sample handling, shipping and processing. The cfDNA and CTCs isolated from stored plasma can be used in next generation sequencing assays that have been cleared or approved for use with samples collected into Cell-Free DNA BCT.
Cold chain free – Transport samples at room temperature
Simplify your blood sample analysis with Cell-Free DNA BCT
Watch this video to learn more about how Cell-Free DNA BCT mitigates pre-analytical variation, eliminating the need for immediate plasma isolation.
LabX webinar: Don’t let compromised sample integrity break your heart
While stabilization tubes allow for long-term room temperature storage, it can be difficult to know which is the right one for your needs. How do you know when you’ve found “the one?”
Ordering Information
| Description | Catalog Number |
|---|---|
| 6-tube pack (10.0 mL) – 16mm x 100mm | 230469 |
| 100-tube box (10.0 mL) – 16mm x 100mm | 230470 |
| 1000-tube case (10.0 mL) – 16mm x 100mm | 230471 |
Order Cell-Free DNA BCT today
New customers
Existing customers
Citations
Resources
Instructions (IFU)
Product Information
Certificates
- Cell-Free DNA BCT IVD CoA Lot 3254 2024-12-19
- Cell-Free DNA BCT IVD CoA Lot 3282 2025-01-17
- Cell-Free DNA BCT IVD CoA Lot 3301 2025-02-07
- Cell-Free DNA BCT IVD CoA Lot 3305 2025-02-21
- Cell-Free DNA BCT IVD CoA Lot 3333 2025-03-04
- Cell-Free DNA BCT IVD CoA Lot 3346 2025-03-18
- Cell-Free DNA BCT IVD CoA Lot 3362 2025-04-02
- Cell-Free DNA BCT IVD CoA Lot 4046 2025-05-13
- Cell-Free DNA BCT IVD CoA Lot 4068 2025-07-01
- Cell-Free DNA BCT IVD CoA Lot 4095 2025-07-29
- Cell-Free DNA BCT IVD CoA Lot 4107 2025-08-12
- Cell-Free DNA BCT IVD CoA Lot 4198 2025-10-01
- Cell-Free DNA BCT IVD CoA Lot 4211 2025-10-15
- Cell-Free DNA BCT IVD CoA Lot 4233 2025-11-20
- Cell-Free DNA BCT IVD CoA Lot 4248 2025-12-03
- Cell-Free DNA BCT IVD CoA Lot 4262 2025-12-17
- Cell-Free DNA BCT IVD CoA Lot 4305 2026-01-01
Looking for an older document? Click here for archived assays and certificates.
Stabilization Products
With our patented portfolio of stabilization solutions, you can ship and store samples at room temperature, mitigating pre-analytical variation in critical samples, easing handling concerns and allowing for batch processing.
RNA Complete BCT
A blood collection tube that maintains the draw time concentration of cell-free RNA and extracellular vesicles, such as exosomes, for up to 7 days at room…
Cell-Free DNA BCT RUO & CE
A blood collection tube that stabilizes cell-free DNA for up to 14 days at 6 °C to 37 °C* and CTCs for up to 7 days at 15 °C to 30 °C*. It is available…
Nucleic Acid BCT
A direct draw venous whole blood collection device that maintains draw-time concentrations of cell-free DNA, cell-free RNA and extracellular vesicles for…
Protein Plus BCT
A direct draw whole blood collection tube intended for the stabilization of draw-time concentrations of plasma proteins for up to 5 days* at ambient temperature…
The latest from the blog
Stabilization
Stabilization
FDA clearance brings liquid biopsy into a new era
With the FDA clearance of several assays, liquid biopsy moves closer toward the goal of making this screening method a standard of care. Liquid biopsy…
Read More 
Stabilization
How can nucleic acids predict disease?
Liquid biopsy is a diagnostic technique where bodily fluids are examined for biomarkers that suggest disease. In recent years, liquid biopsy has been …
Read More 